+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Incidence of extended spectrum beta lactamase producing Escherichia coli among patients, healthy individuals and in the environment



Incidence of extended spectrum beta lactamase producing Escherichia coli among patients, healthy individuals and in the environment



Indian Journal of Medical Microbiology 32(2): 172-174



We investigated the faecal carriage of extended spectrum β-lactamases (ESBL) producing Escherichia coli in different groups of human subjects and in the environment. A total of 363 E. coli strains were isolated from stool samples of patients (n = 77), healthy subjects (n = 170) and from different environmental samples (n = 116). A total of 124 ESBL producing E. coli strains were isolated in this study. The frequency of ESBL producing E. coli was found to be highest (60.3%) among the strains isolated from patients, followed by healthy individuals (38%) and the environment (10.5%). The environment was observed to have a very low number of ESBL producing E. coli.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053790956

Download citation: RISBibTeXText

PMID: 24713906

DOI: 10.4103/0255-0857.129810


Related references

Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infection Control and Hospital Epidemiology 28(9): 1114-1116, 2007

Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates. Clinical Microbiology and Infection 16(2): 132-136, 2010

Approaches to characterize extended spectrum beta-lactamase/beta-lactamase producing Escherichia coli in healthy organized vis-a-vis backyard farmed pigs in India. Infection, Genetics and Evolution 36: 224-230, 2016

Carriage of Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamase in Healthy Vietnamese Individuals. Antimicrobial Agents and ChemoTherapy 59(10): 6611-6614, 2016

Phenotypic characterization of extended-spectrum-beta-lactamase producing E. coli from healthy individuals, patients, sewage sludge, cattle, chickens and raw meat. Pakistan Journal of Medical Sciences 33(4): 886-890, 2017

Prevalence and characterization of extended-spectrum beta-lactamase (ESBL)- and CMY-2-producing Escherichia coli isolates from healthy food-producing animals in Tunisia. Foodborne Pathogens and Disease 9(12): 1137-1142, 2014

Potential pathogenicity and host range of extended-spectrum beta-lactamase-producing Escherichia coli isolates from healthy poultry. Applied and Environmental Microbiology 77(16): 5830-5833, 2011

Prevalence and characterisation of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia. European Journal of Clinical Microbiology and Infectious Diseases 31(7): 1511-1516, 2012

Molecular Characterization of Extended-Spectrum-beta-Lactamase-Producing and Plasmid-Mediated AmpC beta-Lactamase-Producing Escherichia coli Isolated from Stray Dogs in South Korea. 2012

Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. Urology 74(1): 119-123, 2009

High incidence of extended spectrum beta-lactamase producing Klebsiella pneumoniae and Escherichia coli isolates in a specialized facility. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 405, 2001

Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase-producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units. Antimicrobial Agents and ChemoTherapy 52(5): 1846-1849, 2008

Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea. Scandinavian Journal of Infectious Diseases 42(4): 275-280, 2010

In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates. Antimicrobial Agents and ChemoTherapy 43(5): 1170-1176, 1999

Free water surface constructed wetlands limit the dissemination of extended-spectrum beta-lactamase producing Escherichia coli in the natural environment. Water Research 104: 178-188, 2016